The first clinical use of heparin was for chemoprophylaxis in surgical patients. In 1937, Murray and Crafoord published data evaluating surgical patients who received prophylaxis for DVT. 14 Despite ...

The appropriate duration of anticoagulation for venous thromboembolism (VTE) in patients who have a transient provoking factor (e.g., surgery, trauma, or immobility) and concomitant enduring risk ...

A new study published in the International Journal of General Medicine showed that physicians may reliably estimate the ...

Several factors can increase a person’s risk of deep vein thrombosis (DVT) development. Examples include injury to the veins, hormonal changes, reduced blood flow, certain health conditions, and more.

Early mobilization was associated with a lower incidence of deep venous thrombosis (DVT) progression in a randomized trial of 103 patients hospitalized for proximal DVT, but the results did not reach ...

Basilic vein thrombosis is a type of superficial venous thrombosis (SVT) in which a blood clot forms in the basilic vein in the arm. In many cases, SVT is harmless and will resolve without treatment.

Deep vein thrombosis (DVT), a condition that causes a clot in a vein (often in your legs), can sometimes develop without warning—especially when you’re traveling or seated for long stretches at a time ...

The Centers for Disease Control and Prevention estimates that 900,000 people are affected by blood clots each year, and 100,000 of those affected die as a result. The most common type of blood clot is ...